MediBeacon’s Start At the Helix Center
May 18, 2021
39 North‘s Helix Center Biotech Incubator, part of the St. Louis Economic Development Partnership (STL Partnership), is a destination location for bioscience, agricultural technology and […]
Read More
STL Made Galera Therapeutics’ Stock Rises Following Positive Study for Experimental Cancer Therapy
May 11, 2021
Biopharmaceutical company Galera Therapeutics‘ stock price rose 41% after showing results from early-stage testing of its experimental therapy for advanced pancreatic cancer. The company is […]
Read More
St. Louis-born Galera’s stock soars after release of positive study data for its experimental cancer therapy
May 3, 2021
Galera Therapeutics‘ stock price jumped 41% Thursday morning after the St. Louis-born biopharmaceutical company provided updated results from early-stage testing of its experimental therapy for […]
Read More
BioGenerator Partners with STL Partnership Managing Helix Center Core Lab
February 17, 2021
The St. Louis Economic Development Partnership (STL Partnership) and BioGenerator have teamed up to create more space for agtech startups in the Helix Center‘s core […]
Read More
Black Scientists and Their Impact
February 9, 2021
To celebrate Black History Month, we’d like to share this article about prominent Black scientists who made huge impacts on our everyday lives. May we […]
Read More
INVITATION TO BID OLIVE / LINDBERGH INTERCHANGE
December 15, 2020
The St. Louis Economic Development Partnership (SLEDP) is seeking proposals from qualified contractors for the Olive/Lindbergh Interchange Project. Bid documents can be obtained from www.drexeltech.com. […]
Read More